Drug · DIN 02279347
STRATTERA
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since March 21, 2024; first marketed December 16, 2009.
- Drug Identification Number (DIN)
- 02279347
- Company (DIN owner)
- Eli Lilly Canada IncToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Atomoxetine N06BA09
- Class
- Human
- Record last updated
- June 26, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ATOMOXETINE (ATOMOXETINE HYDROCHLORIDE) | 80 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 27, 2006: NOC 8180Supplement to a New Drug Submission (SNDS) · New strengths: 80 mg and 100 mg
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “strattera”. A notice may cover another product or only some lots: read it to see what it covers.
Other DINs named STRATTERA
- DIN 02262800 · Cancelled Post Market
- DIN 02262819 · Cancelled Post Market
- DIN 02262827 · Cancelled Post Market
- DIN 02262835 · Cancelled Post Market
- DIN 02262843 · Cancelled Post Market
- DIN 02279355 · Cancelled Post Market